Dendritic cell based cancer vaccines using adenovirally mediated expression of the HER-2/neu gene and apoptotic tumor cells expressing heat shock protein 70
Human Epidermal Growth Factor Receptor 2 (HER-2/neu) is a breast tumor antigen (Ag) commonly overexpressed in 30% of breast cancer cases. Both HER-2/neu-targeted DNA-based and transgene modified dendritic cell (DC)-based vaccines are potent elements in eliciting HER-2/neu specific antitumor immune r...
Main Author: | |
---|---|
Other Authors: | |
Format: | Others |
Language: | en |
Published: |
University of Saskatchewan
2006
|
Subjects: | |
Online Access: | http://library.usask.ca/theses/available/etd-08232006-203717/ |